Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
3.910
-0.270 (-6.46%)
At close: Feb 21, 2025, 4:00 PM
4.200
+0.290 (7.42%)
After-hours: Feb 21, 2025, 7:22 PM EST
Telomir Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 10.01 | 2.37 | 0.02 | 0.01 |
| Research & Development | 2.24 | 1.57 | 0.83 | 0.13 |
| Operating Expenses | 12.24 | 3.94 | 0.85 | 0.14 |
| Operating Income | -12.24 | -3.94 | -0.85 | -0.14 |
| Interest Expense | -4.34 | -1.64 | - | - |
| Interest & Investment Income | 0.05 | - | - | - |
| EBT Excluding Unusual Items | -16.53 | -5.59 | -0.85 | -0.14 |
| Other Unusual Items | - | -7.49 | - | - |
| Pretax Income | -16.53 | -13.07 | -0.85 | -0.14 |
| Net Income | -16.53 | -13.07 | -0.85 | -0.14 |
| Net Income to Common | -16.53 | -13.07 | -0.85 | -0.14 |
| Shares Outstanding (Basic) | 30 | 27 | 27 | - |
| Shares Outstanding (Diluted) | 30 | 27 | 27 | - |
| Shares Change (YoY) | 8.18% | 1.77% | - | - |
| EPS (Basic) | -0.56 | -0.48 | -0.03 | - |
| EPS (Diluted) | -0.56 | -0.48 | -0.03 | - |
| Free Cash Flow | -5.07 | -3.86 | -0.47 | -0.12 |
| Free Cash Flow Per Share | -0.17 | -0.14 | -0.02 | - |
| EBIT | -12.24 | -3.94 | -0.85 | -0.14 |
Source: S&P Capital IQ. Standard template.
Financial Sources.